Free Trial

Hamilton Lane (NASDAQ:HLNE) Coverage Initiated at BMO Capital Markets

Hamilton Lane logo with Finance background

Key Points

  • BMO Capital Markets has initiated coverage on Hamilton Lane (NASDAQ:HLNE) with an "outperform" rating and a price target of $150.00, indicating an anticipated upside of 18.53% from its previous close.
  • In recent analyst activity, Hamilton Lane received a mix of ratings, with one analyst giving a "Strong Buy," while others ranged from "sell" to "neutral," leading to a consensus rating of "Hold."
  • Hamilton Lane reported a quarterly earnings surprise, posting an EPS of $1.31, exceeding estimates by $0.33, alongside revenue growth of 11.8% year-over-year.
  • Interested in Hamilton Lane? Here are five stocks we like better.

Investment analysts at BMO Capital Markets started coverage on shares of Hamilton Lane (NASDAQ:HLNE - Get Free Report) in a research note issued on Friday,Benzinga reports. The brokerage set an "outperform" rating and a $150.00 price target on the stock. BMO Capital Markets' target price suggests a potential upside of 18.53% from the stock's previous close.

Several other analysts also recently weighed in on HLNE. Wall Street Zen downgraded shares of Hamilton Lane from a "hold" rating to a "sell" rating in a research report on Saturday, September 20th. Wells Fargo & Company boosted their target price on shares of Hamilton Lane from $161.00 to $162.00 and gave the stock an "equal weight" rating in a research report on Friday, July 11th. JPMorgan Chase & Co. dropped their target price on shares of Hamilton Lane from $153.00 to $145.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 23rd. Keefe, Bruyette & Woods boosted their target price on shares of Hamilton Lane from $160.00 to $168.00 and gave the stock a "market perform" rating in a research report on Wednesday, August 6th. Finally, The Goldman Sachs Group raised shares of Hamilton Lane from a "sell" rating to a "neutral" rating and boosted their target price for the stock from $149.00 to $162.00 in a research report on Thursday, September 18th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, Hamilton Lane presently has a consensus rating of "Hold" and an average price target of $164.38.

Read Our Latest Analysis on HLNE

Hamilton Lane Trading Down 1.7%

NASDAQ HLNE opened at $126.55 on Friday. The company has a quick ratio of 4.32, a current ratio of 4.32 and a debt-to-equity ratio of 0.29. The firm has a market cap of $7.05 billion, a PE ratio of 24.34 and a beta of 1.20. The company has a 50 day moving average price of $150.01 and a 200 day moving average price of $150.21. Hamilton Lane has a 52 week low of $124.10 and a 52 week high of $203.72.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.31 EPS for the quarter, topping the consensus estimate of $0.98 by $0.33. The firm had revenue of $196.73 million during the quarter, compared to analyst estimates of $166.96 million. Hamilton Lane had a net margin of 30.66% and a return on equity of 29.47%. Hamilton Lane's revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.47 EPS. As a group, sell-side analysts forecast that Hamilton Lane will post 4.97 EPS for the current fiscal year.

Insider Activity at Hamilton Lane

In other news, major shareholder River 5 Ltd French sold 150,000 shares of the company's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $146.51, for a total value of $21,976,500.00. Following the sale, the insider directly owned 330,015 shares of the company's stock, valued at $48,350,497.65. This represents a 31.25% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 22.21% of the stock is owned by company insiders.

Institutional Trading of Hamilton Lane

A number of hedge funds have recently added to or reduced their stakes in the company. Corient Private Wealth LLC acquired a new stake in Hamilton Lane during the second quarter valued at $206,000. Osaic Holdings Inc. grew its position in Hamilton Lane by 802.0% during the second quarter. Osaic Holdings Inc. now owns 5,782 shares of the company's stock valued at $825,000 after buying an additional 5,141 shares during the period. Squarepoint Ops LLC grew its position in Hamilton Lane by 54.7% during the second quarter. Squarepoint Ops LLC now owns 20,695 shares of the company's stock valued at $2,941,000 after buying an additional 7,314 shares during the period. Hudson Bay Capital Management LP acquired a new stake in Hamilton Lane during the second quarter valued at $671,000. Finally, Caxton Associates LLP acquired a new stake in Hamilton Lane during the second quarter valued at $1,180,000. 97.40% of the stock is owned by hedge funds and other institutional investors.

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

See Also

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hamilton Lane Right Now?

Before you consider Hamilton Lane, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.

While Hamilton Lane currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.